Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Journal of the American Academy of Dermatology 2025 Aug 29
Ultralow-dose rituximab in pemphigus: Weighing clinical benefits against immunologic limitations.
×
To continue please login or register
Register
or
Sign in
